• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SHIRAKAWA OLYMPUS CO., LTD. EVIS LUCERA ULTRASOUND GASTROVIDEOSCOPE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SHIRAKAWA OLYMPUS CO., LTD. EVIS LUCERA ULTRASOUND GASTROVIDEOSCOPE Back to Search Results
Model Number GF-UCT260
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Apnea (1720); Hemorrhage/Bleeding (1888); Low Blood Pressure/ Hypotension (1914); Hypoxia (1918); Sepsis (2067); Rupture (2208); Peritonitis (2252); Pancreatitis (4481); Unspecified Hepatic or Biliary Problem (4493)
Event Date 05/17/2022
Event Type  Injury  
Event Description
Olympus reviewed the following literature titled "propensity score matching analysis for adverse events of eus-guided biliary drainage in advanced elderly (peace study)." this multicenter, retrospective study was aimed to determine the safety of endoscopic ultrasound-guided biliary drainage (eus-bd) for advanced elderly patients.A total of 271 patients who underwent eus-bd were enrolled in this study (group a=177, group b=94).The types of adverse events that were associated with eus-bd was observed in 38 patients, and they did not differ significantly between two groups.Adverse events were associated with sedation after propensity score matching; hypoxemia and severe hypoxemia were significantly higher in group a compared with group b.This study concluded that eus-bd could be safety performed in advanced elderly patients, the same as in younger patients.Also, capnographic monitoring might be helpful in case of sedation by a gastroenterologist in a non-intubated patient.Type of adverse events/number of patients.Procedure-related adverse events (38) bile peritonitis 24 , bleeding 4, pancreatitis 5, biloma 2, sepsis 2.Procedure-related late adverse events (27) cholangitis 25, hepatic artery rupture 2.Sedation-related adverse events (67), hypoxemia 34, severe hypoxemia 20 , apnea 2, hypotension 11.Death 1.This literature article requires 2 reports.The related patient identifiers are as follows: (b)(6): for the death, (b)(6): for adverse events other than death.This medwatch report is for patient identifier (b)(6).There is no report of any olympus device malfunction in any procedure described in this study.
 
Manufacturer Narrative
The suspect device has not been returned to olympus for evaluation.The investigation is in process.The literature article is attached for additional information.Once the investigation has been completed, a supplemental report will be submitted with device evaluation results.
 
Manufacturer Narrative
This supplemental report is being submitted to provided additional information from the author (see b5).
 
Event Description
Additional information received from the author: the authoring physician stated: this is a nuanced article stating that respiratory-related complications can be prevented by means of monitoring, and has nothing to do with endoscopic instruments.
 
Manufacturer Narrative
This report is being supplemented to provide additional information based on the legal manufacturer's final investigation.The device history record was unable to be reviewed for this device since the serial and/or lot number was not provided.However, olympus only releases products to market that meet all manufacturing specifications and final product release criteria.Based on the results of the investigation, the relationship between the device and the adverse event cannot be confirmed.There was no complaint reported on the subject device.There is no evidence of an olympus device malfunction.Therefore, the root cause cannot be determined.This supplemental report includes information added to g2.Olympus will continue to monitor field performance for this device.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EVIS LUCERA ULTRASOUND GASTROVIDEOSCOPE
Type of Device
ULTRASOUND GASTROVIDEOSCOPE
Manufacturer (Section D)
SHIRAKAWA OLYMPUS CO., LTD.
3-1 okamiyama
odakura, nishigo-mura,
nishishirakawa-gun, fukushima 961-8 061
JA  961-8061
Manufacturer Contact
masaharu hirose
3-1 okamiyama
odakura, nishigo-mura,
nishishirakawa-gun, fukushima 961-8-061
JA   961-8061
426422891
MDR Report Key15458770
MDR Text Key300301829
Report Number3002808148-2022-02216
Device Sequence Number1
Product Code ODG
Combination Product (y/n)N
Reporter Country CodeJA
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Study,Literature,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 11/01/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberGF-UCT260
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 08/21/2022
Initial Date FDA Received09/20/2022
Supplement Dates Manufacturer Received10/17/2022
10/12/2022
Supplement Dates FDA Received10/27/2022
11/01/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
Treatment
NON-OLYMPUS, 0.025-INCH GUIDEWIRE; NON-OLYMPUS, 19 G NEEDLE; NON-OLYMPUS, BALLOON CATHETER; NON-OLYMPUS, ELECTROCAUTERY DILATOR; NON-OLYMPUS, MECHANICAL DILATOR; NON-OLYMPUS, STENTS
Patient Outcome(s) Required Intervention; Other;
-
-